Savers Value Village (SVV) insider exercise and sale under 10b5-1 plan

Rhea-AI Filing Summary

Insider transactions by Savers Value Village, Inc. (SVV): On 09/05/2025 Melinda L. Geisser exercised 14,000 stock options at an exercise price of $1.41 per share and purchased 14,000 shares. On the same date she sold 14,000 shares at $12.98 per share pursuant to a 10b5-1 trading plan adopted March 10, 2025. After these transactions the reporting person is recorded as beneficially owning 508,373 shares/option-equivalents.

Positive

• Transaction executed under a documented 10b5-1 plan (adopted March 10, 2025), which provides pre-established trading rules
• Officer retains substantial beneficial ownership: 508,373 shares/options remain beneficially owned after the reported transactions

Negative

• Insider sold 14,000 shares on 09/05/2025 at $12.98 per share, representing a monetization of holdings

Insights

Corporate Governance Expert

TL;DR: Officer exercised vested options then sold an equal number of shares under a pre-established 10b5-1 plan; remaining holdings stay significant.

The Form 4 shows an officer-level insider exercising 14,000 options granted under the 2019 Management Incentive Plan and immediately selling 14,000 shares under a 10b5-1 plan adopted March 10, 2025. The filing discloses that the option grant schedule included time-based and performance-based vesting and that a substantial balance (508,373 shares/options) remains beneficially owned. From a governance perspective, use of a documented 10b5-1 plan reduces questions about timing but does not change the fact of a monetization event.

Securities Analyst

TL;DR: Transaction is routine insider exercise and sale; material impact appears limited to insider liquidity.

The report details exercise at $1.41 and sale at $12.98 for 14,000 shares on 09/05/2025. The options exercised were from a 2019 grant that fully vested in part by 03/28/2024, and the filing notes approximately 508,373 option-linked shares remain beneficially owned. There is no disclosure of additional transfers, company-level corporate actions, or changes to outstanding share count in this Form 4.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Geisser Melinda L.

(Last) (First) (Middle)

C/O SAVERS VALUE VILLAGE, INC.

11400 SE 6TH, SUITE 125

(Street)

BELLEVUE WA 98004

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Savers Value Village, Inc. [ SVV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief People Services Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/05/2025		M		14,000	A	$1.41	14,000	D
Common Stock	09/05/2025		S(1)		14,000	D	$12.98	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Purchase)(2)	$1.41	09/05/2025		M			14,000	(3)	06/12/2029	Common Stock	14,000	$1.41	508,373(4)	D

Explanation of Responses:

1. The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 10, 2025.

2. Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions.

3. The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024.

4. Approximately 25% represents time-based options which vested in substantially equal annual installments over 5 years starting March 28, 2020 and approximately 75% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.

Remarks:

	/s/ Richard Medway, attorney in fact	09/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Melinda L. Geisser report on the SVV Form 4?

The Form 4 reports that on 09/05/2025 Melinda L. Geisser exercised 14,000 options at an exercise price of $1.41 and sold 14,000 shares at $12.98 pursuant to a 10b5-1 plan.

Was the sale by the SVV insider part of a planned trading arrangement?

Yes. The sale was executed pursuant to a 10b5-1 plan adopted by the reporting person on March 10, 2025 as disclosed in the Form 4.

How many shares/options does the reporting person beneficially own after the transactions?

The Form 4 shows the reporting person beneficially owns 508,373 shares/option-equivalents following the reported transactions.

What was the source of the exercised options reported on the SVV Form 4?

The options were previously granted under the registrant's 2019 Management Incentive Plan; vesting included time-based and performance-based components.

What vesting details are disclosed for the reported option grant?

The filing states the June 12, 2019 grant vested in equal annual installments over five years starting March 28, 2020 and was fully vested on March 28, 2024; approximately 25% are time-based and 75% performance-based options.